Cellectis Short Long Term Debt Total from 2010 to 2024
| CLLS Stock | USD 2.82 0.08 2.76% |
Short and Long Term Debt Total | First Reported 2008-12-31 | Previous Quarter 84 M | Current Value 92.9 M | Quarterly Volatility 42.5 M |
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.4 M, Interest Expense of 5.6 M or Selling General Administrative of 30.4 M, as well as many exotic indicators such as Price To Sales Ratio of 244, Dividend Yield of 0.0 or PTB Ratio of 1.97. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
Cellectis | Short Long Term Debt Total |
Latest Cellectis' Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of Cellectis SA over the last few years. It is Cellectis' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Cellectis Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 41,808,217 | |
| Geometric Mean | 10,413,688 | |
| Coefficient Of Variation | 108.39 | |
| Mean Deviation | 41,435,352 | |
| Median | 5,674,875 | |
| Standard Deviation | 45,317,077 | |
| Sample Variance | 2053.6T | |
| Range | 111.3M | |
| R-Value | 0.70 | |
| Mean Square Error | 1123.6T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | 7,107,323 | |
| Total Sum of Squares | 28750.9T |
Cellectis Short Long Term Debt Total History
About Cellectis Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cellectis income statement, its balance sheet, and the statement of cash flows. Cellectis investors use historical funamental indicators, such as Cellectis's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Cellectis investors may use each financial statement separately, they are all related. The changes in Cellectis's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cellectis's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cellectis Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cellectis. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 92.9 M | 97.5 M |
Pair Trading with Cellectis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cellectis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will appreciate offsetting losses from the drop in the long position's value.Moving together with Cellectis Stock
| 0.7 | EWTX | Edgewise Therapeutics | PairCorr |
Moving against Cellectis Stock
| 0.57 | MRSN | Mersana Therapeutics | PairCorr |
| 0.51 | KROS | Keros TherapeuticsInc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Cellectis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cellectis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cellectis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cellectis SA to buy it.
The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cellectis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cellectis SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cellectis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cellectis Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Cellectis Stock analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Cellectis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectis. If investors know Cellectis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellectis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 0.161 | Quarterly Revenue Growth (0.89) | Return On Assets (0.20) | Return On Equity (1.11) |
The market value of Cellectis SA is measured differently than its book value, which is the value of Cellectis that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectis' value that differs from its market value or its book value, called intrinsic value, which is Cellectis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellectis' market value can be influenced by many factors that don't directly affect Cellectis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellectis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellectis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellectis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.